Clinical characteristics of all subjects.

NAFLD, AFLD, HBV, HCV patients and age-and gender-matched control subjects were enrolled from 2006 to 2013. Significant differences existed in the levels of ALT, AST, TG and BMI between non-NASH and NASH cases. ** Between Non-NASH and NASH groups, significant at P < 0.01. ## Among NAFLD, HBV, HCV group, significant at P < 0.05. $$ Among NAFLD, HBV, HCV group, significant at P < 0.01 Clinical characteristics of all subjects.